CombiMatrix Corporation Logo

Print Print page   Email Email page   PDF Download PDF    Add to Briefcase
« Previous Release | Next Release »

CombiMatrix to Participate in the RedChip Emerging Growth Showcase

IRVINE, Calif., Jan. 17, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that CEO Mark McDonough is scheduled to participate in the RedChip Emerging Growth Showcase at 2:00 pm EST on Thursday, January 23, 2014, at The showcase, a digital conference, is being held January 22-23, 2014.

To view the presentation via CombiMatrix's website, go to in the Investor/Events section ( A replay of the webcast will be available for 30 days at the site after the presentation.

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support for the highest quality of care - specializing in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix offers comprehensive testing services for the detection of genetic abnormalities at the DNA level, beyond what can be identified through traditional methodologies. The Company performs genetic testing utilizing advanced technologies, including microarray, FISH, PCR and G-Band chromosome analyses. Additional information about CombiMatrix is available at or by calling 1-800-710-0624.

CONTACT: Company Contact:

         Mark McDonough

         President & CEO, CombiMatrix Corporation

         Tel (949) 753-0624

         Investor Contact:

         Matt Clawson


         Allen & Caron

         Tel (949) 474-4399

         Media Contact:

         Len Hall

         VP, Media Relations

         Allen & Caron

         Tel (949) 474-4300

CombiMatrix Corporation

Source: CombiMatrix Corporation

News Provided by Acquire Media

Close window | Back to top